Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases

NCT02471170 | Enrolling By Invitation DMC

• 1 other identifier: UPCC 02215
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to collect blood samples to detect potential markers of pancreatic cancer in the blood and link these findings to medical and health information. Information from this study may help to provide insight into the detection of pancreas cancer in the blood before it can be found by other methods or provide a method of monitoring the status of pancreatic cancer throughout a treatment course. Another purpose of this study is to collect blood to create a biobank.

Conditions

Pancreatic Diseases

Outcome Measures

Primary Outcomes (1)

• Collection of blood and tissue samples from subjects with pancreatic diseases

  3 years

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

subjects with pancreatic diseases

You may qualify if:

• The subject must be a patient at the Hospital of the University of Pennsylvania
• The subject must be under evaluation and/or treatment for a pancreatic disease
• The subject must be under evaluation and/or treatment for a non-pancreatic disease. For example, patients undergoing routine colonoscopy within the clinical practice will be asked to consent to provide control samples.
• The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf
• The subject must be 18 years of age or older

You may not qualify if:

• The subject or acceptable surrogate does not provide informed consent
• Subject is a prisoner
• Subject is under 18 years of age

Sponsors & Collaborators

• Abramson Cancer Center at Penn Medicine: lead

Study Sites (1)

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

The frequency of research blood collection will not exceed 60 mL in a 1 week period and will not occur more frequently than 4 times in an 8 week period.

MeSH Terms

Conditions

Pancreatic Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

• Peter O'Dwyer, MD

  Abramson Cancer Center at Penn Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 11, 2015
• First Posted: June 15, 2015
• Study Start: September 10, 2015
• Primary Completion (Estimated): January 1, 2035
• Study Completion (Estimated): January 1, 2035
• Last Updated: April 4, 2025

Record last verified: 2025-04

Locations

US (1)